TechFlow news, December 10 — According to Bloomberg Terminal, MicroStrategy (MSTR) is expected to replace biotech company Moderna (MRNA) and join the Nasdaq-100 Index (NASDAQ-100).
Add to Favorites
Share to Social Media
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
